Hepatitis B Vaccine (Recombinant) Completed Phase 3 Trials for Chronic Kidney Disease (CKD) Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00985426Immunogenicity and Safety of HEPLISAV™ Hepatitis B Virus Vaccine in Chronic Kidney Disease (CKD) Patients